Cargando…
Intravenous Administration of Triptonide Attenuates CFA-Induced Pain Hypersensitivity by Inhibiting DRG AKT Signaling Pathway in Mice
BACKGROUND: Currently, medical treatment of inflammatory pain is limited by a lack of safe and effective therapies. Triptonide (TPN), a major component of Tripterygium wilfordii Hook.f. with low toxicity, has been shown to have good anti-inflammatory and neuroprotective effects. The present study ai...
Autores principales: | Ling, Yue-Juan, Ding, Ting-Yu, Dong, Fu-Lu, Gao, Yong-Jing, Jiang, Bao-Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718987/ https://www.ncbi.nlm.nih.gov/pubmed/33293856 http://dx.doi.org/10.2147/JPR.S275320 |
Ejemplares similares
-
Triptonide inhibits metastasis potential of thyroid cancer cells via astrocyte elevated gene-1
por: Fu, Liangjie, et al.
Publicado: (2020) -
Electroacupuncture Attenuates CFA-Induced Inflammatory Pain by Regulating CaMKII
por: Gu, Yixiao, et al.
Publicado: (2020) -
Identification of triptonide as a therapeutic agent for triple negative breast cancer treatment
por: Gao, Bowen, et al.
Publicado: (2021) -
Triptonide is a reversible non-hormonal male contraceptive agent in mice and non-human primates
por: Chang, Zongliang, et al.
Publicado: (2021) -
Tripterygium wilfordii cytochrome P450s catalyze the methyl shift and epoxidations in the biosynthesis of triptonide
por: Hansen, Nikolaj Lervad, et al.
Publicado: (2022)